期刊文献+

重组人粒-巨噬细胞集落刺激因子临床新应用进展 被引量:10

原文传递
导出
摘要 重组人粒一巨噬细胞集落刺激因子(rhGM-CSF)是一种重要的多功能造血生长因子,可刺激多系造血细胞的增殖和分化,促进中性粒细胞、单核一巨噬细胞及血小板等的增殖和分化。因而被广泛应用于治疗患者放、化疗后的骨髓抑制,以及骨髓移植、再生障碍性贫血、骨髓增生异常综合征等患者相关的白细胞减少症。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第5期429-431,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献18

  • 1Metcalf D. The molecular biology and functions of the ranulocyte- macrophage colony-stimulating factors. Blood, 1986, 67:257-267.
  • 2Schuurman B, Heuff G, Beelen RH, et al. Enhanced killing ca- pacity of human Kupffer cells after activation with human granulo- cyte/macrophage-colony-stimulating factor and interferon-γ. Canc- er lmmunol Immunother, 1994, 39 : 179-184.
  • 3Oosterling S J, Mels AK, Geijtenbeek TB, et al. Preoperative gran- ulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients. Immunobiology, 2006, 211:641-649.
  • 4Cartron G, Zhao-Yang L, Baudard M, et al. Granulocyte-macro- phage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase lI study. J Clin Oncol, 2008, 26:2725-2731.
  • 5Karmali R, Larson ML, Wooldridge JE, et al. Granulocyte-macro- phage colony stimulating factor-induced immune priming of cyclo- phosphamide, doxorubicin, vincristine, and prednisone with ritux- imab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma. Leuk Lymphoma, 2011,52 : 2097-2104.
  • 6Chang JE, Seo S, Kim KM, et al. Rituximab and CHOP chemo- therapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin oneology network study. Clin Lymphoma Myeloma Leuk, 2010, 10:379-384.
  • 7Font A, Moyano AJ, Puerto JM, et al. Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group. Cancer, 1999, 85:855-63.
  • 8Correale P, Miano ST, Remondo C, et al. Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetax- el + / - granulocyte-macrophage colony stimulating factor and low dose aldesleukine. Cancer Biol Ther, 2009, 8 : 497-502.
  • 9Rodenhuis S, Bontenbal M, Beex LV, et al. High-dose chemo- therapy with hematopoietic stem-cell rescue for high risk breast cancer. N Engl J Med, 2003, 349: 7-16.
  • 10Kuzhan O, Ozet A, Ulutin C, et al. Survival benefit with GM- CSF use after high-dose chemotherapy in high-risk breast cancer. Tumori, 2007, 93:550-556.

同被引文献101

引证文献10

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部